BioLife Sciences Inc. (BLFE) Stock
BioLife Sciences Corp. specializes in the creation, licensing, and distribution of both antibacterial solutions and advanced non-contact human temperature screening technologies.
Valuation
Financials & Margins
Annual Financials (USD)
Balance Sheet (USD)
Cash Flow (USD)
Valuation & Return Ratios
Ownership
Peer Comparison
About BioLife Sciences Inc.
BioLife Sciences Corp. specializes in the creation, licensing, and distribution of both antibacterial solutions and advanced non-contact human temperature screening technologies. Its diverse product portfolio includes sanitizing wipes, ultraviolet (UV) sterilization equipment, professional electrostatic disinfection services, specialized anti-microbial fabrics, and innovative touch-free vending or marketplace systems. The company, which was established in 2018, operates from its base in Mississauga, Canada.
BioLife Sciences Inc. (BLFE) stock trades at $0.00 with a market capitalization of $156683. The stock is valued at a price-to-earnings (P/E) ratio of 0.00, price-to-book of -0.01, price-to-sales of 0.38. Over the past 52 weeks the stock has ranged between $0.00 and $0.00, and currently trades —% below its 52-week high.
On profitability, BioLife Sciences Inc. generates a return on equity (ROE) of 100.00% — well above the market average, a sign of a high-quality business, return on capital employed of 180.40%, an operating margin of 0.00%, a net profit margin of 0.00%.
Official website: www.biolifesciences.com